Successful treatment of disseminated interdigitating dendritic cell sarcoma with adriamycin, bleomycin, vinblastine, and dacarbazine chemotherapy
Korean Journal of Hematology
;
: 150-153, 2012.
Artículo
en Inglés
| WPRIM
| ID: wpr-720180
ABSTRACT
Interdigitating dendritic cell sarcoma (IDCS) is a very rare and aggressive neoplasm that arises from antigen presenting cells. IDCS usually involves lymph nodes; however, extra-nodal involvement has also been reported. Because a consistent standard therapy for IDCS has not been established to date, we report a case of the successful treatment of disseminated IDCS using ABVD chemotherapy (doxorubicin, bleomycin, vinblastine, and dacarbazine). A 64-year-old man was diagnosed with IDCS on the basis of immunohistochemical findings of a biopsy specimen of the inferior nasal concha. Immunohistochemical staining showed a positive reaction for CD68, leukocyte common antigen, and S-100 protein, but a negative reaction for CD34, CD1a, and CD21. Imaging studies showed cervical and axillary lymphadenopathies, subcutaneous nodules, and a soft tissue lesion in the nasal cavity. Treatment with the ABVD regimen resulted in complete remission after 8 cycles of chemotherapy.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Cornetes Nasales
/
Vinblastina
/
Biopsia
/
Bleomicina
/
Células Dendríticas
/
Proteínas S100
/
Antígenos Comunes de Leucocito
/
Dacarbazina
/
Sarcoma de Células Dendríticas Interdigitantes
/
Células Presentadoras de Antígenos
Límite:
Humanos
Idioma:
Inglés
Revista:
Korean Journal of Hematology
Año:
2012
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS